BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

VIRalliance

VIRalliance develops and markets high added value services and products to help optimise drug discovery and patient treatment in the fields of infectious diseases and oncology.VIRalliance has a development portfolio of innovative predictive tests to aid the optimal treatment.
PHENOSCRIPT™ is the first of these tests to be made available to the public.
PHENOSCRIPT™ is a novel and rapid HIV phenotypic test used to measure resistance to antiretroviral drugs used in HIV therapy. Treatment failure can occur in HIV/AIDS patients when the virus develops resistance to drug therapy. Physicians use the test to select the most effective HIV drug therapy for the individual patient.
With more clinically relevant cut-offs than any other commercially available HIV drug susceptibility test, the PHENOSCRIPT™ Report provides clear and concise recommendations to facilitate the choice of optimal treatments.
The superior reliability and accuracy of PHENOSCRIPT™ have been validated through extensive study by independent investigators.


Contact Details:
59, boulevard du Général Martial Valin
Paris
75015
France
Tel:33 (0) 1 45 58 76 00
Fax:33 (0) 1 45 58 08 81
Email:viralliance@viralliance.com
WWW:

www.VIRALLIANCE.COM/




Recent Publications by VIRalliance:

Synergistic inhibition of protease-inhibitor-resistant HIV type 1 by saquinavir in combination with atazanavir or lopinavir.
BACKGROUND: Double-boosted protease inhibitors (PIs) are under...
7th August, 2007
Viralliance, Paris, France. Antivir Ther. 2007;12(3):371-80.

BioNews Results for VIRalliance:

BioAlliance Pharma SA : Q3 2008: Significant Progression and Consolidation of Fundamentals
FinanzNachrichten.de:  Oct 30 2008 6:30AM Matching: viralliance
BioAlliance Pharma Was Informed That a Civil Action Was Filed by Eurofins in the United States
Pharma Live:  Oct 14 2008 7:49PM Matching: viralliance

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 262 times since April 2007, the link to the organisation's website has been followed 52 times

Recent Search Terms used to find this page: viralliance | Viralliance | viralliance | viralliance | viralliance | viralliance | VIRalliance Paris France | phenoscript cut-offs | eurofins viralliance | Viralliance | .

Search for more companies in Paris

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for VIRalliance

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.